補完体受容体におけるアナフィラトキシン結合,活性化,シグナルバイアスの分子基礎
Manish K Yadav1, Jagannath Maharana1, Ravi Yadav2
1Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
Cell
|October 18, 2023
まとめ
補完性アナフィラトキシン受容体C3aRとC5aR1に関する構造的な洞察は,それらの受容体がどのようにリガンドと結合し,免疫反応を活性化するかを明らかにする. この研究は,炎症性疾患に対する薬の発見に役立ちます.
科学分野:
- 免疫学
- 構造生物学
- 生物化学
背景:
- 補完体系は 生まれつきの免疫に不可欠です
- アナフィラトキシンC3aとC5aは,C3aRとC5aR1のGタンパク質結合受容体 (GPCR) を介して信号を発する.
- C3aRとC5aR1の活性化とシグナリングのメカニズムは,まだ十分に理解されていません.
研究 の 目的:
- 補完体アナフィラトキシン受容体の活性化とシグナル伝達の分子メカニズムを解明する.
- リガンド認識とトランスデューサー結合のための構造的基礎を提供する.
- C3aとC5aによる炎症反応の調節メカニズムを明らかにする.
主な方法:
- クリオ電子顕微鏡 (cryo-EM) で,9つの異なる受容体-リガンド複合体の構造を決定する.
- 結合ポケットのトポロジーと受容体の活性化状態の分析
- 新型C3aRアゴニストの特定とそのシグナリングバイアスの特徴づけ.
主要な成果:
- C3aRとC5aR1内のコンプリメントアナフィラトキシンに対する明確な結合ポケットアーキテクチャ.
- C5a媒介の炎症反応をタンパク質分裂によって抑制する構造的基礎.
- C3aRペプチドアゴニストのGタンパク質シグナルバイアスの特定
結論:
- コンプリメントアナフィラトキシン受容体の構造的基礎の解明
- 受容体の活性化,シグナルバイアス,および調節に関する洞察を提供します.
- C3aRとC5aR1を標的とした炎症性および自己免疫疾患に対する構造主導の薬剤発見を容易にする.
関連する概念動画
Complement System
2.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.4K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Allergic Drug Reactions
852
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
852
Cross-reactivity
31.2K
Overview
31.2K
Antibody Structure
60.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.2K
Allergic Reactions
27.6K
Overview
27.6K


